Dr Graeme Young | Manager, Drug Metabolism and Pharmacokinetics
Glaxo Smith Kline R & D

Dr Graeme Young, Manager, Drug Metabolism and Pharmacokinetics, Glaxo Smith Kline R & D

Graeme Young, Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research andDevelopment Ltd.
BSc (Hons) Biochemistry from Heriot-Watt University, Edinburgh, Scotland (1982-1986)
MSc Forensic Science from Strathclyde University, Glasgow, Scotland (1986-1987).
Employed at GSK (or heritage companies) within departments of Drug Metabolism for over 25 years. Acted as a "champion" of Accelerator Mass Spectrometry for many years, with responsibility for bringing AMS in-house and applying it to projects within GSK. Lead author or contributing author to many papers published on the subject of AMS and its application to Drug Metabolism and Bioanalysis.  Currently chair of the Global Bioanalysis Consortium team on AMS.

back to speakers

Co-located with Biomarkers World Europe:

  • Exploratory Clinical Development World Europe 2015